Speak directly to the analyst to clarify any post sales queries you may have.
The hospice care market in the United States is undergoing rapid transformation, evolving in response to demographic shifts, technological advancement, and policy changes. This comprehensive report equips senior decision-makers with a clear view of current dynamics, future growth opportunities, and the strategic imperatives required to succeed in the changing hospice landscape.
Market Snapshot: U.S. Hospice Market Growth and Trajectory
The hospice market grew from USD 129.67 billion in 2024 to USD 139.59 billion in 2025. It is projected to continue on an upward path, experiencing a compound annual growth rate (CAGR) of 8.04% and reaching USD 240.82 billion by 2032. Market expansion is propelled by an aging population, the increasing prevalence of chronic illnesses, and a systemic push towards value-based care models that emphasize quality of life and patient autonomy.
Scope & Segmentation of the Hospice Market
This market research report delivers granular insight into hospice market segmentation and operational breadth, covering:
- Service Types: Counselling services, medical supply services, nursing services, and physician services
- Care Types: Continuous home care, general inpatient care, inpatient respite care, and routine home care
- Application Settings: Facility-based care (hospice centers, hospitals, skilled nursing facilities) and home-based care
- Patient Conditions: Cancer, cardiovascular diseases, chronic kidney disease, HIV/AIDS, neurological disorders, respiratory diseases
- Regions covered: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
- Companies profiled: Thirty major providers, including AccentCare, Agape Care Group, Amedisys, BAYADA, Compassus, Gentiva, Hope Hospice, Humana, LHC Group, VITAS Healthcare by Chemed Corporation, and others
Key Takeaways: Strategic Insights for Senior Decision-Makers
- Hospice care models prioritize holistic well-being, combining medical, psychosocial, and spiritual support to enhance patient outcomes over purely curative approaches.
- Industry leaders are leveraging telehealth and digital monitoring platforms to strengthen service accessibility and reduce avoidable hospitalizations, particularly in rural and home-based settings.
- Workforce development is pivotal, as organizations enhance specialized training and mentorship for coordinating interdisciplinary hospice teams and meeting complex case needs.
- Collaborative alliances across providers, academic centers, and technology partners serve as catalysts for innovation in care delivery models and operational efficiency.
- Market consolidation and targeted acquisitions are reshaping competitive dynamics, empowering established networks to expand geographic presence and standardize clinical protocols.
Tariff Impact on Supply Chains and Cost Structures
Recent U.S. tariff changes on imported medical goods are reshaping supply chains and operational budgets for hospice providers. Increased duties on essential supplies, such as infusion pumps and wound dressings, have compelled organizations to audit procurement strategies, negotiate with domestic distributors, and diversify sourcing to maintain uninterrupted service. Group purchasing alliances and agile logistics are increasingly vital in mitigating cost pressures and safeguarding patient access to care.
Methodology & Data Sources
This report synthesizes insights from primary sources—expert interviews, executive surveys—and an in-depth review of regulatory filings, clinical studies, trade publications, and association reports. All findings are validated through data triangulation, benchmarking, and advanced statistical analysis for accuracy and relevancy to senior leaders.
Why This Report Matters
- Enables strategy formulation based on actionable segmentation, regional differentiation, and competitive dynamics within the hospice care market.
- Equips decision-makers with essential knowledge to adjust procurement, workforce, and partnership strategies amid regulatory and tariff-driven market changes.
- Supports future-focused planning by clarifying the operational impacts of new technologies, care models, and reimbursement structures.
Conclusion
The hospice market is positioned for sustained evolution, driven by emerging service models, regulatory shifts, and advancing technologies. Senior decision-makers will benefit from timely insights to inform growth strategies, resource allocation, and innovation in quality hospice delivery.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this Hospice market report include:- AccentCare, Inc.
- Agape Care Group
- Amedisys, Inc.
- Amvis Holdings, Inc.
- BAYADA Home Health Care
- Care24 Pvt Ltd.
- Community Hospice & Palliative Care
- Compassus
- Dierksen Hospice
- Elara Caring
- Enhabit, Inc.
- Envision Healthcare Holdings, Inc
- Gateway Hospice & Palliative Care
- Genesis Healthcare, Inc.
- Gentiva
- Heart to Heart Hospice
- Hope Hospice Inc.
- Humana Inc.
- Interim HealthCare Inc
- Jeevodaya Hospice
- LHC GROUP, INC.
- Lifepath Hospice Care Services
- Option Care Health Inc.
- Sage Hospice Holdings, LLC
- St Andrew’s Hospice
- Traditions Health, LLC
- Trustbridge, Inc
- VITAS Healthcare by Chemed Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 193 |
| Published | November 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 139.59 Billion |
| Forecasted Market Value ( USD | $ 240.82 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |


